Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
18.45
-0.26 (-1.39%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Takeda Pharmaceutical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Takeda Pharmaceutical stock has a consensus rating of "Strong Buy" and an average price target of $21.89. The average 1-year stock price forecast is 18.64% higher than the current stock price, while the lowest is $20.89 (+13.22%) and the highest is $22.94 (+24.34%).
Price Target: $21.89 (+18.64%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Takeda Pharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $43 | Buy | Maintains | $43 | +130.61% | Aug 13, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $21 | Buy | Maintains | $21 | +13.82% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
4.69T
from 4.51T
Increased by 4.19%
Revenue Next Year
4.77T
from 4.69T
Increased by 1.67%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.